Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0FL7O
|
||||
Former ID |
DNC012639
|
||||
Drug Name |
4-Biphenyl-4-yl-2-(1-pentyl-hexyl)-1H-imidazole
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527102] | ||
Structure |
Download2D MOL |
||||
Formula |
C26H34N2
|
||||
Canonical SMILES |
CCCCCC(CCCCC)C1=NC=C(N1)C2=CC=C(C=C2)C3=CC=CC=C3
|
||||
InChI |
1S/C26H34N2/c1-3-5-8-14-24(15-9-6-4-2)26-27-20-25(28-26)23-18-16-22(17-19-23)21-12-10-7-11-13-21/h7,10-13,16-20,24H,3-6,8-9,14-15H2,1-2H3,(H,27,28)
|
||||
InChIKey |
FAJKZAIMTCYING-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Sodium channel | Target Info | Inhibitor | [527102] | |
Voltage-gated sodium channel subunit alpha Nav1.3 | Target Info | Inhibitor | [527102] | ||
KEGG Pathway | Dopaminergic synapse | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.